Health & Fitness
Mon, February 20, 2012
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16, 2012 at 2:00 p.m. EST, at Citias 2012 Global Health Care Conference on Tuesday, February 28, 2012 at 2:00 p.m. EST and at the 2012 RBC Global Healthcare Conference on Wednesday, February 29, 2012 at 10:00 a.m. EST.
The presentations will be webcast live and may be accessed from aEvents & Presentationsa on the home page of Vertexas website at [ www.vrtx.com ]. A replay of the webcasts will also be available on the Companyas website for two weeks following the presentations. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and Science magazine named Vertex number one on its 2011 list of Top Employers in the life sciences.
Vertexas press releases are available at [ www.vrtx.com ].
(VRTX-WEB)
